Oklahoma 2023 Regular Session

Oklahoma House Bill HCR1009

Introduced
5/11/23  

Caption

Designating Hypertrophic Cardiomyopathy Awareness Day and efforts to educate people about hypertrophic cardiomyopathy.

Impact

The resolution notably supports statewide efforts to educate citizens about hypertrophic cardiomyopathy and improve public cardiovascular health. By officially recognizing an awareness day, it creates a platform for healthcare providers and organizations to conduct outreach and educational programs focused on HCM, helping to inform the public about its risks, symptoms, and available treatments. The acknowledgment of such a day represents a step towards addressing a public health issue that affects many but is often overlooked.

Summary

HCR1009 is a Concurrent Resolution that aims to designate the fourth Wednesday in February as 'Hypertrophic Cardiomyopathy Awareness Day' in Oklahoma. This resolution is significant as it seeks to raise awareness about hypertrophic cardiomyopathy (HCM), a chronic cardiovascular disease that remains largely undiagnosed among the population. With an estimated 700,000 individuals in the United States affected by HCM, the resolution emphasizes the need for education about this disease, its symptoms, and the importance of early diagnosis and management options available to patients.

Sentiment

The sentiment surrounding HCR1009 appears to be overwhelmingly positive, with legislators and health advocates expressing support for the initiative. Supporters argue that creating an awareness day can improve health outcomes by encouraging individuals to seek medical advice and testing for HCM. This proactive approach to public health is viewed as essential for reducing the prevalence of undiagnosed cases and enabling timely treatment.

Contention

While the resolution itself is largely non-controversial, it serves as a reminder of the ongoing challenges in the awareness and treatment of genetic cardiovascular conditions like HCM. The potential for broader advocacy may lead to further discussions regarding healthcare access, genetic testing, and resources allocated for the education of both patients and medical professionals regarding HCM.

Companion Bills

No companion bills found.

Similar Bills

NJ SJR119

Designates fourth Wednesday of February each year as Hypertrophic Cardiomyopathy Awareness Day in NJ.

NJ S3983

Requires DOH to create and disseminate materials and resources related to cardiomyopathy; appropriates $300,000.

NJ A5043

Requires DOH to create and disseminate materials and resources related to cardiomyopathy.

ME SP0957

JOINT RESOLUTION DESIGNATING FEBRUARY 28, 2024 AS HYPERTROPHIC CARDIOMYOPATHY AWARENESS DAY

US HB6829

HEARTS Act of 2024 Cardiomyopathy Health Education, Awareness, and Research, and AED Training in the Schools Act of 2024

UT SCR004

Concurrent Resolution Encouraging Hypertrophic Cardiomyopathy Awareness and Screening

CA SR14

Relative to hypertrophic cardiomyopathy.

CA SCR20

Peripartum Cardiomyopathy Awareness Month.